FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing triptorelin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only formestane (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing formestane (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only fulvestrant in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Fulvestrant 50 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only fulvestrant (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing fulvestrant (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing fulvestrant in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing letrozole (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only letrozole in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Letrozole only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Letrozole 2.5 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Letrozole-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing leuprorelin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only leuprorelin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 7.5 mg/mL suspension for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 20 mg/mL suspension for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing leuprorelin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 11.25 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 3.75 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing megestrol (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Megestrol only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only megestrol (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely megestrol acetate 125 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Megestrol acetate 40 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Megestrol acetate 160 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Megestrol acetate 40 mg/mL oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Some
Megestrol acetate 20 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing megestrol in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lenalidomide only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lenalidomide only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely lenalidomide 10 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing lenalidomide (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lenalidomide 5 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lenalidomide-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lenalidomide 20 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lenalidomide 2.5 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely lenalidomide 25 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lenalidomide 15 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing peginterferon alfa-2b (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing peginterferon alfa-2b in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Peginterferon alfa-2b only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only peginterferon alfa-2a (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only peginterferon alfa-2a in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only ibritumomab tiuxetan (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing ibritumomab tiuxetan (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only cyproterone in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only cyproterone (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyproterone acetate 100 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyproterone acetate 50 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon alfa-2a (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Peginterferon alfa-2a-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only interferon alfa-2a in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2a only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing peginterferon alfa-2a (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon alfa-2a in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon alfa-2b (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only interferon alfa-2b in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Peginterferon alfa-2b only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b 1 million unit powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon alfa-2b in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only interferon alfa-n1 (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon alfa-n1 (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only interferon alfacon-1 in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only interferon alfacon-1 (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon alfacon-1 (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfacon-1-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon beta-1a (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing peginterferon beta-1a (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only peginterferon beta-1a (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1a only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only interferon beta-1a (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1a 24 million unit/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1a 30 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon beta-1a in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon beta-1b (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only interferon beta-1b in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1b only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon beta-1b 300 microgram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1b-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 13 of 17 Next End

This concept is not in any reference sets

Back to Start